Similar to the correlation of expression and tumor grading, ERBB2 overexpression was detected in 39/61 advanced UTUCs staged 2–4, but only in 9 tumors staged 0 and in 13 tumors staged 1 (p > 0.359). Here, ERBB2 is linked to neoplasm.